Dr Adam Januszewski

MBBS AICSM AFMLM MRCP(Onc) PhD
GMC: 7020418
5.01 reviewReview

Professional statement

Dr Adam Januszewski is a medical oncology consultant in central London with specialist expertise in lung cancer, immunotherapy, targeted therapy, clinical trials, chemotherapy, early-stage lung cancer and personalised medicine. He privately practises at Nuffield Health at St Bartholomew’s Hospital, while his NHS base is Barts Health NHS Trust, where he also serves as divisional lead for quality and safety at Barts Cancer Centre.


Dr Januszewski is a thoracic oncologist with a strong focus on patient-centred care and expanding access to innovative treatments through clinical research. He is the UK chief investigator for several international phase 2 and 3 trials and co-manages the clinical research delivery team at St Bartholomew’s Hospital. His academic background includes a PhD in genomic medicine from Imperial College London and a postgraduate diploma in cancer biology from The Institute of Cancer Research.


He is active in shaping national oncology services through his roles on the British Thoracic Oncology Group steering committee, the UK Lung Cancer Coalition and as a NICE technology appraiser. He also contributes to the development of national consent guidance with Cancer Research UK.


Dr Januszewski is committed to advancing personalised cancer treatment and ensuring patients have access to the latest therapies. He regularly presents at international conferences and contributes to scientific literature on lung cancer and precision oncology. He is a member of several professional bodies, including the Royal College of Physicians, European Society of Medical Oncology and the International Association for the Study of Lung Cancer.

Clinics

  • Nuffield Health at St Bartholomew's Hospital
  • E-consultation

Credentials

Professional experience

  • 18 years of experience
  • Medical oncology consultant, Barts Health NHS Trust

Subspecialties

  • Early-stage lung cancer

Professional memberships

  • International Association for the Study of Lung Cancer
  • British Thoracic Oncology Group
View more

Education

  • PhD, Genome Sciences/Genomic, Imperial College London (2015 - 2019)
  • PGDip, Oncology and Cancer Biology, The Institute of Cancer Research, University of London (2012 - 2014)
View more

Positions in organisations

  • Divisional Lead for Quality and Safety (Barts Cancer Centre)
  • Co-Manager of the Clinical Research Deliver Team, St Bartholomew’s Hospital
View more

Publications and conferences

  • Georgia Hardavella, Dimitrios E. Magouliotis, Roberto Chalela, Adam Januszewski, Fabio Dennstaedt, Paul Martin Putora, Alfred So, Angshu Bhowmik. Breathe 2024 20: 230219; DOI: 10.1183/20734735.0219-2023
  • McInnerney D, Quaife S, Cooke S, Michinson L, Pogson Z, Ricketts W, Januszewski A, Lerner A … Peak M, Nelson D (2024). Understanding the impact of distance and disadvantage on lung cancer are and outcomes: a study protocol. BMC Cancer 2;24(1):942
View more

Languages spoken

  • English
Registration number: 7020418

Content

Reviews

All reviews are from real patients and have been verified by our Customer Service department to ensure they meet our guidelines. Rules of the service
  • Would you recommend this doctor?
  • Treatment of the doctor
  • Treatment of the staff
  • Waiting time
  • Condition of facilities
  • I met to Dr. Adam Januszewski to discuss about my father for lung cancer. Doctor asked me to send me all the reports to study the case before consulting. By talking almost an hour he made each and everything crystal clear. Discussing all the points, answering my all the questions
    21 August 2025

    A.K.

    Verified patient

Treatments

Frequently Asked Questions

The doctor, or where applicable the hospital or medical centre in which the doctor provides services, undertakes to keep the information relating to the prices of services published on their profile on the Top Doctors platform up to date at all times, ensuring that such prices correspond to those effectively charged to patients. In the event of any discrepancy between the published price and the price ultimately charged to the patient, the doctor and/or the relevant hospital or medical centre shall be solely liable towards the patient and towards Top Doctors for any claim or financial difference arising therefrom.